Earnings History Data for Tricida, Inc. (TCDA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Tricida, Inc.

Tricida, Inc. is a late-stage pharmaceutical company. It focuses on the discovery and clinical development of novel therapeutics to address renal, metabolic and cardiovascular diseases. The company's product candidate consists of TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. Tricida, Inc. is based in CA, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2022	PM	4:05 PM ET (Nov 14)	TCDA	Tricida, Inc.	13.60	-0.44	-0.54	-0.79	Tricida GAAP EPS of -$0.44 beats by $0.10 [11/15/2022 6:16 AM]	0.2456	-0.02 (-7.84%)	0.28	0.01 (3.90%)	0.23 - 13.85	9,468,710	16,050,000	493,354
Tricida GAAP EPS of -$0.44 beats by $0.10 [11/15/2022 6:16 AM] Tricida Announces Third Quarter 2022 Financial Results [Nov-14-22 04:05PM]
08-08-2022	AH	4:05 PM ET (Aug 8)	TCDA	Tricida, Inc.	501.04	-0.49	-0.52	-0.67	Tricida GAAP EPS of -$0.49 beats by $0.09 [8/8/2022 4:16 PM]	12.39	1.59 (14.72%)	10.80	0.0 (0.00%)	3.80 - 13.36	1,290,505	380,000	4,675
Tricida GAAP EPS of -$0.49 beats by $0.09 [8/8/2022 4:16 PM] Tricida Announces Second Quarter 2022 Financial Results [Aug-08-22 04:05PM]
10-05-2022	AH	4:05 PM ET (May 10)	TCDA	Tricida, Inc.	442.74	-0.51	-0.64	-1.06	Tricida GAAP EPS of -$0.51 beats by $0.15 [5/10/2022 4:44 PM]	7.31	-0.01 (-0.14%)	7.68	0.36 (4.92%)	3.55 - 12.45	752,192	470,000	176
Tricida GAAP EPS of -$0.51 beats by $0.15 [5/10/2022 4:44 PM] Tricida Announces First Quarter 2022 Financial Results [May-10-22 04:05PM]
29-03-2022	AH	4:05 PM ET (Mar 29)	TCDA	Tricida, Inc.	468.68	-0.92	-0.71	-1.09	Tricida GAAP EPS of -$0.92 misses by $0.24 [3/29/2022 4:11 PM]	8.08	0.12 (1.51%)	7.66	-0.05 (-0.65%)	3.55 - 10.92	254,461	350,000	2
Tricida GAAP EPS of -$0.92 misses by $0.24 [3/29/2022 4:11 PM] Tricida Announces Fourth Quarter and Full Year 2021 Financial Results [Mar-29-22 04:05PM]
08-11-2021	AH	4:05 PM ET (Nov 8)	TCDA	Tricida, Inc.	267.78	-0.79	-0.70	-1.55	Tricida EPS misses by $0.10 [11/8/2021 4:32 PM]	5.26	-0.16 (-2.95%)	4.84	-0.58 (-10.70%)	3.55 - 8.19	484,972	120,000	53,576
Tricida EPS misses by $0.10 [11/8/2021 4:32 PM] Tricida Announces Third Quarter 2021 Financial Results [Nov-08-21 04:05PM]
09-08-2021	AH	4:05 PM ET (Aug 9)	TCDA	Tricida, Inc.	200.09	-0.67	-0.72	-1.16	Tricida EPS beats by $0.17 [8/9/2021 4:47 PM]	4.14	-0.07 (-1.66%)	4.25	0.04 (0.95%)	3.55 - 15.33	317,084	350,000	427
Tricida EPS beats by $0.17 [8/9/2021 4:47 PM] Tricida Announces Second Quarter 2021 Financial Results [Aug-09-21 04:05PM]
06-05-2021	AH	4:10 PM ET (May 6)	TCDA	Tricida, Inc.	229.75	-1.06	-0.89	-1.49	Tricida EPS misses by $0.03 [5/6/2021 4:36 PM]	4.06	0.11 (2.78%)	4.06	0.0 (0.00%)	3.74 - 32.99	236,963	330,000	1,591
Tricida EPS misses by $0.03 [5/6/2021 4:36 PM] Tricida, Inc. to Host Earnings Call [May-06-21 02:30PM] Tricida Announces First Quarter 2021 Financial Results [May-06-21 04:05PM] CORRECTING and REPLACING -- Tricida Announces First Quarter 2021 Financial Results [May-06-21 05:07PM]
25-02-2021	AH	4:05 PM ET (Feb 25)	TCDA	Tricida, Inc.	350.29	-1.09	-1.04	-1.17	Tricida reports Q4 results [2/25/2021 4:27 PM]	5.10	-2.26 (-30.69%)	5.23	-2.13 (-28.94%)	3.74 - 35.16	5,087,277	870,486	77,679
Tricida reports Q4 results [2/25/2021 4:27 PM] Tricida falls after announcing appeal denied letter on trial for chronic kidney disease [2/25/2021 5:12 PM] Here's Why Tricida Shares Plummeted Today [Feb-26-21 02:00PM] The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida [Feb-26-21 08:16AM] Why Is Tricida Trading Lower? [Feb-26-21 06:22AM] SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tricida, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2021 - TCDA [Feb-25-21 09:09PM] The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SWI, QS and TCDA [Feb-25-21 06:45PM] CLASS ACTION UPDATE for TCDA, EBIX and APA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Feb-25-21 04:40PM]
05-08-2020	AH	4:05 PM ET (Aug 5)	TCDA	Tricida, Inc.	668.36	-1.16	-1.49	-0.75	Tricida EPS beats by $2.62 [8/5/2020 4:22 PM]	13.83	0.03 (0.22%)	13.73	-0.07 (-0.51%)	12.91 - 44.30	464,242	675,033	7,614